FTLD patients with Parkinsonism showed significantly higher levels of plasma MCP-1 (U = 345, p = 0.030) and, conversely, lower levels of the anti-inflammatory IL-10 (U = 404, p = 0.016) compared to FTLD patients without Parkinsonism. This evidence concerns the gene CCL2 and Parkinson disease.